Recombinant Human Deoxyribonuclease 1 class drugs

1 result
  • pulmozyme

    (dornase alfa)
    Genentech, Inc.
    PULMOZYME® is indicated for managing cystic fibrosis in pediatric and adult patients to improve pulmonary function and reduce the risk of respiratory tract infections requiring parenteral antibiotics in those with an FVC ≥ 40% of predicted, when used alongside standard therapies.